Free Cash Flow

A new campaign by Palvella Therapeutics and key partners aims to educate and empower patients with a rare disease, a strategic move ahead of a potential new drug.

DuPont honors veterans at THE PLAYERS Championship while showcasing how its battlefield-proven materials are now revolutionizing high-performance golf equipment.

A new survey finds companies are dynamically adjusting investment hurdles in response to market chaos, leveraging technology to navigate an uncertain world.

After 15 years without new therapies, Tonix Pharma's TONMYA enters the fibromyalgia market with a unique sublingual drug and an ambitious commercial plan.

Amid historic defense budgets, COPT Defense heads to a key conference, poised to showcase its robust financial health and critical role in national security.

Hallador Energy appoints M&A veteran Daniel Hudson to its board and promotes Heath Lovell to COO, signaling a major push to expand its power platform.

Despite lower revenue, the railcar maker expanded margins and cash flow in 2025, signaling a resilient strategy focused on diversification for 2026.

BETA Technologies will launch electric air services across 10 states, deploying its ALIA aircraft for cargo, medical, and critical logistics missions.

Ottawa injects over $900M into defence innovation, fueling a new strategy to boost domestic tech, meet NATO commitments, and create high-skill jobs.

Healthcare data giant Cotiviti appoints Waystar's Ric Sinclair as new CEO, signaling a strategic shift to accelerate platform innovation and growth.

With defense spending hitting $2.6T, a new arms race in Edge AI is on. Discover how specialized tech is enabling autonomous warfare and reshaping conflict.

As Capricor prepares its Q4 earnings call, all eyes are on its DMD drug Deramiocel's FDA path, financial health, and next-gen exosome technology.

Medicus Pharma's microneedle patch for basal cell carcinoma clears nearly three-quarters of lesions, offering a potential non-surgical alternative to the scalpel.

With new data on CUE-401, a novel therapy inspired by Nobel-winning science, Cue Biopharma makes a high-stakes play to redefine autoimmune treatment.

With 300 million monthly players, a simple puzzle game is quietly dominating the app stores. Here’s how Block Blast! turned relaxation into a global hit.

With record backlogs and surging demand from AI and energy transition, Quanta's March 31st event will reveal new targets shaping the future of infrastructure.

Canada Nickel secures a critical power deal with Hydro One, a major step for its net-zero nickel mine, built on a foundation of Indigenous partnership.

Brookdale Senior Living reports a major year-over-year occupancy jump, outpacing seasonal norms and reflecting a powerful recovery across the senior care sector.

With new federal funding and key milestones met, E3 Lithium's DLE technology is set to unlock vast lithium resources from Alberta's oil brines.

Early access programs for a rare blindness therapy in France, Israel, and the US offer hope to patients and provide a crucial financial lifeline for the company.